MRVI
Maravai LifeSciences Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.32
−0.68%Margins
Gross margin
34.6%
EBITDA margin
-27.4%
EBIT margin
46.0%
Net margin
-37.1%
FCF margin
-16.8%
-37.8%
Return on equity
-12.8%
Return on assets
25.2%
Return on invested capital
0.32x
Asset turnover
-$25.3M
Cash from operations
$0.47
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026